Mengyang Liu

2.9k total citations
107 papers, 2.2k citations indexed

About

Mengyang Liu is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Mengyang Liu has authored 107 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 26 papers in Surgery and 21 papers in Epidemiology. Recurrent topics in Mengyang Liu's work include Cholesterol and Lipid Metabolism (7 papers), Liver Disease Diagnosis and Treatment (7 papers) and Immune cells in cancer (7 papers). Mengyang Liu is often cited by papers focused on Cholesterol and Lipid Metabolism (7 papers), Liver Disease Diagnosis and Treatment (7 papers) and Immune cells in cancer (7 papers). Mengyang Liu collaborates with scholars based in China, United States and Australia. Mengyang Liu's co-authors include Qian Chen, Tao Wang, Yajun Duan, Yuanli Chen, Jingya Ruan, Haiyang Yu, Yanzhi Song, Xiaoju Li, Xinrong Liu and Xuehong Chen and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and ACS Catalysis.

In The Last Decade

Mengyang Liu

98 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengyang Liu China 28 793 424 295 233 188 107 2.2k
Lu Lu China 29 1.3k 1.6× 389 0.9× 266 0.9× 228 1.0× 130 0.7× 156 2.9k
He He China 30 1.3k 1.7× 435 1.0× 281 1.0× 182 0.8× 224 1.2× 91 2.7k
Xuanbin Wang China 29 1.1k 1.4× 272 0.6× 388 1.3× 155 0.7× 224 1.2× 83 2.4k
Jian Liu China 28 1.4k 1.8× 252 0.6× 381 1.3× 300 1.3× 266 1.4× 271 3.2k
Xufeng Tao China 29 1.3k 1.6× 407 1.0× 318 1.1× 342 1.5× 267 1.4× 66 2.7k
Jing Gong China 31 1.0k 1.3× 302 0.7× 271 0.9× 336 1.4× 186 1.0× 101 2.9k
Chia‐Hung Yen Taiwan 32 1.5k 1.9× 367 0.9× 306 1.0× 522 2.2× 126 0.7× 140 3.5k
Yanwei Xing China 31 1.4k 1.7× 249 0.6× 261 0.9× 172 0.7× 268 1.4× 120 3.3k

Countries citing papers authored by Mengyang Liu

Since Specialization
Citations

This map shows the geographic impact of Mengyang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengyang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengyang Liu more than expected).

Fields of papers citing papers by Mengyang Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengyang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengyang Liu. The network helps show where Mengyang Liu may publish in the future.

Co-authorship network of co-authors of Mengyang Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Mengyang Liu. A scholar is included among the top collaborators of Mengyang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengyang Liu. Mengyang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Mengyang, et al.. (2025). Maximizing Lung Transplant Donor Utilization: Developing a Lobar Donor Repository Guided by Chest Computed Tomography Visual Scoring. Interdisciplinary CardioVascular and Thoracic Surgery. 41(1).
3.
Liu, Mengyang, et al.. (2025). Diminishing returns: how treatment delays undermine the mortality benefits of high-quality stroke care. BMJ Quality & Safety. bmjqs–2025.
4.
Li, Zhaohui, et al.. (2024). A novel quantitative method to evaluate lumbar disc degeneration: MRI histogram analysis. European Spine Journal. 33(6). 2420–2429.
5.
Li, Fengyun, Shuting Chen, Gen Li, et al.. (2023). Multifunctional nano-herb based on tumor microenvironment for enhanced tumor therapy of gambogic acid. Chinese Chemical Letters. 35(5). 108752–108752. 5 indexed citations
6.
Wen, Feng, Yi Zhang, Yawei Zhang, et al.. (2023). Anemoside B4 ameliorates dextran sulfate sodium (DSS)-induced colitis through inhibiting NLRP3 inflammasome and modulating gut microbiota. European Journal of Pharmacology. 963. 176164–176164. 8 indexed citations
7.
Liu, Mengyang, et al.. (2023). Characteristics of cardiac involvement in immune-mediated necrotizing myopathy. Frontiers in Immunology. 14. 1094611–1094611. 14 indexed citations
8.
Ban, Rui, et al.. (2023). Identification of novel FHL1 mutations associated with X-linked scapuloperoneal myopathy in unrelated Chinese patients. Journal of Human Genetics. 68(7). 477–484. 1 indexed citations
9.
Li, Zhiwei, Feng Lü, Moning Guo, et al.. (2023). Short‐Term Effects of Carbon Monoxide on Morbidity of Chronic Obstructive Pulmonary Disease With Comorbidities in Beijing. GeoHealth. 7(3). e2022GH000734–e2022GH000734. 2 indexed citations
10.
Wang, Wei, Beibei Chen, Qian Chen, et al.. (2022). Dioscin Ameliorates Hyperuricemia-Induced Atherosclerosis by Modulating of Cholesterol Metabolism through FXR-Signaling Pathway. Nutrients. 14(9). 1983–1983. 11 indexed citations
11.
Chen, Qian, Yuzheng Wu, Haiyang Yu, et al.. (2022). Ginsenoside Compound K Ameliorates Development of Diabetic Kidney Disease through Inhibiting TLR4 Activation Induced by Microbially Produced Imidazole Propionate. International Journal of Molecular Sciences. 23(21). 12863–12863. 18 indexed citations
12.
Wang, Sijian, Miao Liu, Miao Liu, et al.. (2022). Targeting autophagy in atherosclerosis: Advances and therapeutic potential of natural bioactive compounds from herbal medicines and natural products. Biomedicine & Pharmacotherapy. 155. 113712–113712. 18 indexed citations
13.
Liang, Hengrui, Guilin Peng, Mengyang Liu, et al.. (2021). Tubeless video-assisted thoracoscopic surgery in mediastinal tumor resection. Gland Surgery. 10(4). 1387–1396. 3 indexed citations
14.
Yang, Chao, Guilin Peng, Mengyang Liu, et al.. (2019). Eleven cases of heart-lung transplantation: a single centre experience. 13(4). 284–287. 1 indexed citations
15.
Li, Jian, Mengyang Liu, Haiyang Yu, et al.. (2018). Mangiferin Improves Hepatic Lipid Metabolism Mainly Through Its Metabolite-Norathyriol by Modulating SIRT-1/AMPK/SREBP-1c Signaling. Frontiers in Pharmacology. 9. 201–201. 81 indexed citations
16.
Ma, Yuan, Wei Feng, Zhiyuan Wu, et al.. (2018). Intra-tumoural heterogeneity characterization through texture and colour analysis for differentiation of non-small cell lung carcinoma subtypes. Physics in Medicine and Biology. 63(16). 165018–165018. 44 indexed citations
17.
Botchlett, Rachel, Honggui Li, Xin Guo, et al.. (2016). Glucose and Palmitate Differentially Regulate PFKFB3/iPFK2 and Inflammatory Responses in Mouse Intestinal Epithelial Cells. Scientific Reports. 6(1). 28963–28963. 13 indexed citations
18.
Li, Jing, Xia Liu, Mengyang Liu, Kui Che, & Bing Luo. (2016). Methylation and expression of Epstein–Barr virus latent membrane protein 1, 2A and 2B in EBV-associated gastric carcinomas and cell lines. Digestive and Liver Disease. 48(6). 673–680. 14 indexed citations
19.
Ma, Xingzhe, Ying Liu, Qixue Wang, et al.. (2015). Tamoxifen induces the development of hernia in mice by activating MMP-2 and MMP-13 expression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(5). 1038–1048. 22 indexed citations
20.
Li, Hui, et al.. (2010). Study of relationship between ACE and AT1R abnormality in diabetic mellitus.. Xiandai yufang yixue. 37(9). 1759–1763. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026